EXTON, Pa., Dec. 18, 2018 /PRNewswire/ -- West
Pharmaceutical Services, Inc. (NYSE: WST) today announced that
the Company's Board of Directors has approved a first-quarter 2019
dividend of $0.15 per share. The
dividend will be paid on February 6,
2019, to shareholders of record as of January 23, 2019.
The Company also announced that management will be presenting an
overview of the business at the J.P. Morgan Healthcare Conference
in San Francisco, California, at
4:30 p.m. PST on Wednesday, January 9,
2019.
A live audio webcast of the presentation, as well as the
presentation materials, will be accessible from the Company's
website: investor.westpharma.com.
About West
West Pharmaceutical Services, Inc. is a
leading manufacturer of packaging components and delivery systems
for injectable drugs and healthcare products. Working by the side
of its customers from concept to patient, West creates products
that promote the efficiency, reliability and safety of the world's
pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its
customers from locations in North and South America, Europe, Asia
and Australia. West's 2017 net
sales of $1.6 billion reflect the
daily use of approximately 112 million of its components and
devices, which are designed to improve the delivery of healthcare
to patients around the world.
Trademarks and registered trademarks are the property of West
Pharmaceutical Services, Inc. in the
United States and other jurisdictions, unless noted
otherwise.
|
Investor
Contact:
|
Media
Contact:
|
|
Quintin Lai
|
Emily
Denney
|
|
Vice President,
Investor Relations
|
Vice President,
Global Communications
|
|
+1-610-594-3318
|
+1-610-594-3035
|
|
Quintin.Lai@westpharma.com
|
Emily.Denney@westpharma.com
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/west-announces-quarterly-dividend-and-participation-in-upcoming-investor-conference-300767679.html
SOURCE West Pharmaceutical Services, Inc.